• Lipotype goes to Boston

    As a proud sponsoring partner of the 10th Neurodegenerative Drug Development Summit (NDD) in Boston, Lipotype is attending this event from 28th to 30th March.

    read more →

  • A new publication

    As a pioneer in the field of lipidomics, Lipotype not only provides lipidomic analysis services to customers but also contributes to science through carrying out its own research.

    read more →

  • Newly launched blood plasma lipidomics package

    Lipotype launched new analysis packages for population health studies.

    read more →

  • The Lipidomics Webinar

    We all know that genes and proteins are important in biological research. But what about lipids? Lipidomics has proven its usefulness in many studies, but still a lot of scientists do not know about lipidomics and have no clear picture of how it will benefit their research. Hence, we newly launched a webinar series, The

    read more →

  • Turning crisis into progress.

    Even in the midst of a global crisis, COVID-19, there are people who try to make the best of it.

    read more →

  • Diversity Statement

    As biotechnology and pharmaceutical research organizations, we seek to cure diseases, improve health, and secure a better future for everyone in society. Our ability to carry out this important work depends on diversity and internationalism. We stand no chance of succeeding unless we work together and embrace diversity.

    read more →

  • Announcement of the Praemed.Bio Symposium 2020

    The symposium on the regional innovative Wachstumskern Praemed.Bio will take place on-line and in English on 29.10.2020.

    read more →

  • Lipidomics uncovers hidden links between lipids

    Researchers at Oslo University Hospital applied lipidomics when using lipid metabolism inhibitors and discovered an unexpected modulation of lipid metabolism.

    read more →

  • Three New Patents with Lipotype Shotgun Lipidomics

    The month of May came with a set of newly-filed lipidomics patents which made use of Lipotype Shotgun Lipidomics.

    read more →

  • Statement about COVID-19

    Dear friends and fellow researchers, We are closely following the development of this pandemic and have taken appropriate measures to ensure the safety of everyone at Lipotype and her/his family. Nearly all of us are working from home. The analytical team keeps the machines running in order to ensure business works normally. We receive samples,

    read more →